Rankings
▼
Calendar
ORKA Q2 2024 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ORKA
Oruka Therapeutics, Inc.
$1B
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$21M
Net Income
-$22M
EPS (Diluted)
$-1.30
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$34M
Total Liabilities
$1M
Stockholders' Equity
$33M
Cash & Equivalents
$33M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$29,000
+100.0%
Operating Income
-$21M
-$2M
-989.4%
Net Income
-$22M
-$1M
-1402.9%
← FY 2024
All Quarters
Q3 2024 →